Participants were asked if the infection for either infectious mononucleosis (glandular fever) or Covid had been confirmed by a test. For mono, this would be a lab test, which is often done in severe cases. I can't remember if the Covid question includes the option includes a home test.Are they referring to something else when they say "small minority"? 63% is clearly not a minority.
They refer to "documented" infection. Is there data on what proportion of these infections in DecodeME were "documented"?
DecodeME really is groundbreaking. It's the first bite of the cake.
At least the Norwegian members of COFFI argue for fatigue being a spectrum, with CFS on the extreme end. So I'd say they don't see a difference between ME and other fatigue.But DecodeME is studying ME/CFS. I'm not sure they realise there's a difference between ME/CFS and all fatiguing conditions.
a biopsychosocial approach, which is clearly helping many people to reduce symptoms and some to recover.
There are a range of strategies for rehabilitation, drawing on the biopsychosocial explanation of this condition. These include cognitive behaviour therapy, approaches to safely increase activity and mind-body approaches. The research indicates these options may help people reduce symptoms and ensure some recover.
Plausible deniability is important if you’re shilling an untested cure.That seems a bit anaemic from the BPS people.
"just maybe you might recover"
"not with that attitude"
COFFI please get in touch, I’ve got some magic beans to sell to you!
Some people just don’t want their beans to grow, do they.Caffeine-free I hope.
I wonder if professors Daniel Clauw and Andrew Lloyd are still involved with Coffi. I am not their biggest fan but this seems a bit desperate, unscientific and silly even for them.So at point7 it gets all Garnerish and doesn’t make sense, so I stopped reading
Yup. That is exactly what they will do, indeed are already doing via FND, rather successfully thus far unfortunately.Will some of them see which way the wind is blowing and take pragmatic action? Will they go quiet on ME/CFS and just look for other soft targets to exploit?
They seem to be assigning a dx of FND to those with an exisiting diagnosis of MECFS or just going straight to FND and ignoring the MECFS symptoms altogether. It's just backdoor CBT and GET.Will some of them see which way the wind is blowing and take pragmatic action? Will they go quiet on ME/CFS and just look for other soft targets to exploit?
That is exactly what they are doing, and have been for some time.They seem to be assigning a dx of FND to those with an exisiting diagnosis of MECFS or just going straight to FND and ignoring the MECFS symptoms altogether. It's just backdoor CBT and GET.
The much reduced DecodeME team have no capacity or funding to do so, however the cohort is obviously there if some other research team with funding wished to recruit participants from it for such a project.The recovery point creates an interesting opportunity - DecodeME *should* keep track of those who recover in the future and examine reported experiences of those people. DecodeME has a very large, relatively unbiased cohort that could be great for following people over time.
We've discussed this idea and possible problems for it on a decodeme follow-up thread: https://www.s4me.info/threads/what-...e-using-the-decodeme-cohort.45191/post-625666, https://www.s4me.info/threads/what-...e-using-the-decodeme-cohort.45191/post-625965. I think it is worthwhile pursuing, whoever ends up doing it. Maybe COFFI people were reading that thread?I think it is worth pushing that idea out there for those who have funding...
Lloyd is in the executive committee and co-chair with Wyller in the steering committee. Clauw is in the scientific advisory committee.I wonder if professors Daniel Clauw and Andrew Lloyd are still involved with Coffi. I am not their biggest fan but this seems a bit desperate, unscientific and silly even for them.
No, SequenceME doesn't plan to re-assess ME/CFS status of the samples it would be using that were collected as part of DecodeME.I wonder what the plan with SequenceME will be. They might recontact participants but I'm unsure whether they also re-plan to assess "ME/CFS status" (whether alternative diagnosis have come up or whether the symptoms still match the criteria), but if SequenceME does plan to assess "ME/CFS status" then you'd already have a cohort of non-recovered people after a certain time, which could already be interesting.